Overview
- Editors:
-
-
Arthur E. Frankel
-
Department of Medicine Division of Hematology/Oncology, Duke University Medical Center, Durham, USA
Access this book
Other ways to access
Table of contents (30 chapters)
-
-
-
-
How Toxins Work
-
-
- Sjur Olsnes, Kirsten Sandvig
Pages 39-73
-
-
Toxin Selection and Modification
-
-
-
- F. K. Jansen, B. Bourrie, P. Casellas, D. Dussossoy, O. Gros, P. Vic et al.
Pages 97-111
-
- R. J. Youle, L. Greenfield, V. G. Johnson
Pages 113-122
-
-
- Daniel A. Vallera, Dorothea E. Myers
Pages 141-159
-
- David J. FitzGerald, Mark C. Willingham, Ira Pastan
Pages 161-173
-
- John M. Lambert, Walter A. Blättler, Gordon D. McIntyre, Victor S. Goldmacher, Charles F. Scott Jr.
Pages 175-209
-
Covalent Linking Agents
-
Front Matter
Pages 211-211
-
- Jon W. Marsh, Kasturi Srinivasachar, David M. Neville Jr.
Pages 213-237
-
- Edward J. Wawrzynczak, Philip E. Thorpe
Pages 239-251
-
Antibody Selection
-
Front Matter
Pages 253-253
About this book
Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Un fortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up-to-date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by asking eminent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more.
Editors and Affiliations
-
Department of Medicine Division of Hematology/Oncology, Duke University Medical Center, Durham, USA
Arthur E. Frankel